CosLeaguer Global코스리거글로벌

CosLeaguer Global's shares have fallen sharply over the past year as losses deepened in the first half of 2026.

Trailing results to H1 2026 show revenue of ₩102B with an operating loss of ₩5.3B and a net loss of ₩15.5B, and free cash flow of -₩9.0B. Cash of ₩19.9B and borrowings of ₩0.5B are shown, but liabilities are about 7.5 times equity. The company describes itself as operating in healthcare, cosmetics, green technology and new media marketing, with export sales making up most revenue.

What stands out

• Revenue has been volatile: ₩35.7B in 2025 (up 84.4%) after ₩19.3B in 2024, while operating losses widened to ₩8.3B in 2025.
• Trailing net loss of ₩15.5B is much larger than the trailing operating loss, and the 2024 net profit of ₩5.4B was well above its operating loss, so the bottom line is hard to read from the operating figures alone.
• The share price is ₩2,945, down 37.1% over one year and 52-week low is shown as ₩0 in the data, so the range is not reliable here.
• Insider and 5%+ holding reports, plus an amended convertible bond decision and an own convertible bond acquisition, were filed in July and August 2026.
• Foreign ownership is 0.3% and unchanged over 60 days; the data shows no dividend and no analyst or news coverage.

What to watch

• Next quarterly or half-year filings, including the amended H1 2026 half-year report, to see whether losses and negative free cash flow continue.
• Terms and effects of the convertible bond activity and any further 5%+ holding changes shown in filings.
• Leverage: liabilities at 745.6% of equity against limited trailing cash, which the data does not explain further.